MS

Michal Silverberg

Managing Director at novartis venture fund

Greater Boston

Overview 

Michal Silverberg is the Managing Director at Novartis Venture Fund, with a strong background in clinical development and experience in the biotechnology and pharmaceutical industries. Noteworthy highlights include leading investments in companies like Fore Biotherapeutics in Series D and Twentyeight-Seven Therapeutics in Series A.

Work Experience 

novartis venture fund

  • Managing Director

    2017 - Current

TV

Takeda Ventures, Inc.

  • Senior Partner

    2014 - 2017

NN

Novo Nordisk

  • Senior Director Business Development and New Product Commercialization

    2007 - 2013

OSI Pharmaceuticals

  • Manager Business Development

    2006 - 2007

M(

MGVS (Multi Gene Vascular Systems)

  • VP Business Development and Operation

    2003 - 2006

Education 

Investments 

Fore Biotherapeutics

Series D

Total funding: $130M

Twentyeight-Seven Therapeutics

Series A

Total funding: $80M

Articles About Michal

Relevant Websites